Mark A. Fiala, BS, CCRN
Washington University School of Medicine
Division of Oncology, Department of Medicine
Saint Louis, MO, USA

The Impact of Race and Socio-Economic Status on Survival in Multiple Myeloma

Advances in multiple myeloma (MM) therapies have improved overall survival (OS), however, not all population subgroups have benefited equally from these advances. Population-based studies suggest that black patients (pts) with MM have a much higher mortality rate than white pts, however, in several studies, after controlling for treatment, OS was similar or superior for black pts. This discrepancy suggests that the poorer outcomes observed in black pts are attributable to factors other than race, such as socioeconomic status (SES)

Author(s): Mark A Fiala, Joseph D Finney, Jingxia Liu, Keith Stockerl-Goldstein, Michael H. Tomasson, Ravi Vij, Tanya Marya Wildes; Washington University School of Medicine in St. Louis, St. Louis, MO


ABOUT MARK A. FIALA, MSW

Mark A. Fiala is an Instructor in Medicine, Division of Oncology at the Washington University School of Medicine, St. Louis, MO. Visit Mark Fiala’s full biography.

Previous Post
ASCO 2014: Overview of the ASCO 2014 Annual Meeting
Next Post
ASCO 2014: E1A06: A phase III trial comparing MPT versus MPR in newly diagnosed multiple myeloma

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.